$STI
Solidion Technology Inc. Stock $sti

$sti Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024050479 Filed on June 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue		$0.00	$98.05K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit			$300.00
YoY Change
Gross Profit Margin			0.31%
Selling, General & Admin	$3.030M	$1.414M	$1.038M
YoY Change	191.99%	490.22%	734.44%
% of Gross Profit			345930.0%
Research & Development	$729.1K		$760.5K
YoY Change	-4.13%
% of Gross Profit			253495.0%
Depreciation & Amortization	$94.39K		$105.7K
YoY Change	-10.67%
% of Gross Profit			35224.0%
Operating Expenses	$3.759M	$1.414M	$1.038M
YoY Change	262.25%	490.22%	734.5%
Operating Profit	-$3.759M		-$1.742M
YoY Change	115.83%
Interest Expense	$3.739K	-$18.05M	$1.361M
YoY Change	-99.73%	-1787.72%	13506.9%
% of Operating Profit
Other Income/Expense, Net	-$26.01M	$0.00	$1.361M
YoY Change	-2011.3%		15612.4%
Pretax Income	-$29.77M	-$19.46M	$322.9K
YoY Change	-9318.24%	-2445.74%	-388.31%
Income Tax	$0.00	$897.7K	$275.2K
% Of Pretax Income			85.24%
Net Earnings	-$29.77M	-$20.36M	$47.66K
YoY Change	-62555.44%	-3406.16%	-142.55%
Net Earnings / Revenue			48.61%
Basic Earnings Per Share	-$0.38		-$0.02
Diluted Earnings Per Share	-$0.38	-$3.00	$0.00
COMMON SHARES
Basic Shares Outstanding	78.20M shares		69.80M shares
Diluted Shares Outstanding	78.20M shares		69.80M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.824M	$20.00K	$98.05K
YoY Change	1759.87%	-96.33%	-92.27%
Cash & Equivalents	$1.824M	$19.98K	$98.05K
Short-Term Investments
Other Short-Term Assets	$1.362M	$28.33M	$189.3K
YoY Change	619.38%	13039.17%	-4.03%
Inventory	$22.73K	$22.73K
Prepaid Expenses	$334.4K	$85.54K	$189.3K
Receivables	$998.00	$2.164K
Other Receivables	$302.5K	$187.5K
Total Short-Term Assets	$3.512M	$28.35M	$287.4K
YoY Change	1122.03%	3624.11%	-80.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.262M	$2.319M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$42.99M	$130.2M
YoY Change		-66.35%	3.33%
Other Assets	$819.6K
YoY Change
Total Long-Term Assets	$4.988M	$42.99M	$130.2M
YoY Change	-96.17%	-66.36%	3.19%
TOTAL ASSETS
Total Short-Term Assets	$3.512M	$28.35M	$287.4K
Total Long-Term Assets	$4.988M	$42.99M	$130.2M
Total Assets	$8.500M	$71.35M	$130.5M
YoY Change	-93.48%	-44.51%	2.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.866M	$2.131M	$893.0K
YoY Change	220.9%	385.32%	74.94%
Accrued Expenses	$890.4K	$890.0K	$0.00
YoY Change		17700.0%	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.716M	$2.203M	$1.235M
YoY Change	119.94%	1657.62%	885.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$49.13M	$71.21M	$2.743M
YoY Change	1691.04%	7731.44%	317.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.13M	$71.21M	$2.743M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$49.13M	$75.54M	$7.066M
YoY Change	595.35%	1343.78%	41.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$119.7M	-$28.53M	-$6.110M
YoY Change	1859.31%	632.55%
Common Stock	$8.689K	$6.980K	$12.00
YoY Change	72308.33%	58066.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$40.63M	-$28.53M	-$6.110M
YoY Change
Total Liabilities & Shareholders Equity	$8.500M	$71.35M	$130.5M
YoY Change	-93.48%	-44.51%	2.23%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$29.77M	-$20.36M	$47.66K
YoY Change	-62555.44%	-3406.16%	-142.55%
Depreciation, Depletion And Amortization	$94.39K		$105.7K
YoY Change	-10.67%
Cash From Operating Activities	-$2.041M	-$516.1K	-$522.3K
YoY Change	290.71%	1698.26%	20223.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions		$7.250M
YoY Change
Other Investing Activities	-$91.35K	-$62.90K	-$1.035M
YoY Change	-91.17%		-99.18%
Cash From Investing Activities	-$91.35K	-$62.90K	-$1.035M
YoY Change	-91.17%		-99.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$3.850M		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.955M	597.5K	$1.110M
YoY Change	256.41%		-99.13%
NET CHANGE
Cash From Operating Activities	-$2.041M	-516.1K	-$522.3K
Cash From Investing Activities	-$91.35K	-62.90K	-$1.035M
Cash From Financing Activities	$3.955M	597.5K	$1.110M
Net Change In Cash	$1.823M	18.50K	-$447.6K
YoY Change	-507.24%	-164.46%	-135.29%
FREE CASH FLOW
Cash From Operating Activities	-$2.041M	-$516.1K	-$522.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41323
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	13355 Noel Rd
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1100
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	City Area Code CityAreaCode	(972)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	918-5120
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	STI
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86900398	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823601	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	780	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	998	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2164	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	302500	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	187500	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	22730	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22730	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	334366	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44892	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1027557	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3511752	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	258066	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2262058	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2319152	usd
CY2024Q1	sti	Patents Net Of Amortization PatentsNetOfAmortization	1906699	usd
CY2023Q4	sti	Patents Net Of Amortization PatentsNetOfAmortization	1852649	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	819626	usd
CY2024Q1	us-gaap	Assets Assets	8500135	usd
CY2023Q4	us-gaap	Assets Assets	4429867	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2865664	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	144923	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	89267	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	890385	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	41811450	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	527500	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2188769	usd
CY2024Q1	us-gaap	Liabilities Liabilities	49130893	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1017408	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86900398	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86900398	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69800000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69800000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	8689	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6980	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	79158563	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28850985	usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	80241	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119717769	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25445506	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-40630758	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8500135	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4429867	usd
CY2023Q1	us-gaap	Revenues Revenues	300	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	300	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	729114	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	760485	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3030222	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	981632	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3759336	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1742117	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3759336	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1741817	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8182500	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	17820998	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	311	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	3739	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	275	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26006927	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	275	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-29766263	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1741542	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78198418	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69800000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3412459	usd
CY2024Q1	sti	Stock Issued During Period Value Contributions From Related Party StockIssuedDuringPeriodValueContributionsFromRelatedParty	487273	usd
CY2024Q1	sti	Stock Issued During Period Value Issuance Of Common Stock Upon Consummation Of The Merger StockIssuedDuringPeriodValueIssuanceOfCommonStockUponConsummationOfTheMerger	27887919	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3175000	usd
CY2024Q1	sti	Stock Issued During Period Value Stock Subscription Receivable StockIssuedDuringPeriodValueStockSubscriptionReceivable	-80241	usd
CY2024Q1	sti	Adjustments To Additional Paid In Capital Proceeds From Private Warrants AdjustmentsToAdditionalPaidInCapitalProceedsFromPrivateWarrants	8931997	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-262064	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1359000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-29766263	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-40630758	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5983426	usd
CY2023Q1	sti	Adjustment Accumulated Deficitof Distributions And Net Transfers With Related Parties AdjustmentAccumulatedDeficitofDistributionsAndNetTransfersWithRelatedParties	442368	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1741542	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4684252	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-29766263	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1741542	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94392	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	105672	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1359000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8182500	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	17820998	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1164	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-40	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	115000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	124067	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	22780	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1027557	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	819626	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2353747	usd
CY2024Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	17555	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-53321	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	338490	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2040712	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1373441	usd
CY2024Q1	sti	Proceeds From Capitalized Patent Costs ProceedsFromCapitalizedPatentCosts	-91348	usd
CY2023Q1	sti	Proceeds From Capitalized Patent Costs ProceedsFromCapitalizedPatentCosts	-40567	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-91348	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-40567	usd
CY2024Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	487273	usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	812855	usd
CY2024Q1	sti	Cash Received From Nubi Trust CashReceivedFromNUBITrust	25160047	usd
CY2024Q1	sti	Discount Payment Related To Non Redemption Agreement DiscountPaymentRelatedToNonRedemptionAgreement	13937997	usd
CY2024Q1	sti	Payment For Reimbursement Of Consideration Shares Related To The Forward Purchase Agreement PaymentForReimbursementOfConsiderationSharesRelatedToTheForwardPurchaseAgreement	-2193800	usd
CY2024Q1	sti	Payment For Reimbursement Of Recycled Shares Related To Forward Purchase Agreement PaymentForReimbursementOfRecycledSharesRelatedToForwardPurchaseAgreement	80241	usd
CY2024Q1	sti	Business Combination BusinessCombination	8948009	usd
CY2024Q1	sti	Inflow From Merger InflowFromMerger	17555	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	527500	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	424277	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3850000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	-262064	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	241106	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3954881	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	812855	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1822821	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-601153	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	780	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	621575	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1823601	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20422	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	77795	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	1196	usd
CY2024Q1	sti	Common Stock Holdback Shares CommonStockHoldbackShares	200000	shares
CY2024Q1	sti	Merger Agreement Description MergerAgreementDescription	(i) 5,000,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is thirty (30) days following the closing date of the Transactions (the “Closing Date”) until the second anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $12.50 per share (subject to any adjustment pursuant to the Merger Agreement); (ii) 7,500,000 Earnout Shares if, over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the date that is forty-two (42) months following the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $15.00 per share (subject to any adjustment pursuant to the Merger Agreement); and (iii) 10,000,000 Earnout Shares if over any ten (10) trading days within any thirty (30) trading day period from and after the date that is one hundred eighty (180) days following the Closing Date until the fourth anniversary of the Closing Date, the VWAP of the shares of Solidion’s Class A common stock is greater than or equal to $25.00 per share (subject to any adjustment pursuant to the Merger Agreement).
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-29766263	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8182500	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	17820998	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2040712	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1823601	usd
CY2023	us-gaap	Profit Loss ProfitLoss	5324624	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4068302	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2023Q4	us-gaap	Other Receivables OtherReceivables	187500	usd
CY2023	sti	Percentage Of Additional Trust Funding Requirement PercentageOfAdditionalTrustFundingRequirement	0.50	pure
CY2024Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	302500	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	302500	usd
CY2024Q1	us-gaap	Depreciation Depreciation	57094	usd
CY2023Q1	us-gaap	Depreciation Depreciation	92356	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13316	usd
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9500000	shares
CY2024Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9500000	shares
CY2024Q1	sti	Percentage Of Number Of Stocks Of Common Stock Outstanding PercentageOfNumberOfStocksOfCommonStockOutstanding	0.05	pure
CY2023Q1	us-gaap	Other Expenses OtherExpenses	60908	usd
CY2023Q1	sti	Capital Contributions From Related Party CapitalContributionsFromRelatedParty	812855	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	187500	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81948122	shares
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.</p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	sti	Patents Net Of Amortization PatentsNetOfAmortization	1906699	usd
CY2023Q4	sti	Patents Net Of Amortization PatentsNetOfAmortization	1852649	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13316	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	23463	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	24132	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	64015	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	62753	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	8170	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	14500	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	100093	usd
CY2023	sti	Additional Trust Funding Requirement Percentage AdditionalTrustFundingRequirementPercentage	0.50	pure
CY2024Q1	us-gaap	Other Receivables OtherReceivables	302500	usd
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	88979	usd
CY2024Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	906000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	200000	shares
CY2024Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	1910630	usd
CY2024Q1	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	906000	usd
CY2024Q1	sti	Liability At Fair Value Holdback Shares LiabilityAtFairValueHoldbackShares	200000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	522867000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	260803	usd
CY2024Q1	sti	Redeemed Common Stock Percentage RedeemedCommonStockPercentage	1	pure
CY2024Q1	sti	Consideration Receivable Percentage ConsiderationReceivablePercentage	0.70	pure
CY2024Q1	sti	Equity Proceeds Percentage EquityProceedsPercentage	0.60	pure
CY2024Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	18
CY2024Q1	sti	Market Value And New Issue Price Per Share Percentage MarketValueAndNewIssuePricePerSharePercentage	1.80	pure
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	8431850	usd
CY2024Q1	sti	Cash Payment CashPayment	7352	shares
CY2024Q1	sti	Trust Account TrustAccount	80241	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	5838537	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	8038537	shares
CY2024Q1	sti	Cash Payment Paid To Backstop Investors CashPaymentPaidToBackstopInvestors	13937997	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	527500	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	527500	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M18D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0	pure
CY2024Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1359000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P6Y
CY2024Q1	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	4800000	usd
CY2024Q1	sti	Percentage Of Cash Bonus PercentageOfCashBonus	0.025	pure
CY2024Q1	us-gaap	Officers Compensation OfficersCompensation	20000000	usd
CY2024Q1	sti	Proceeds From Fair Value ProceedsFromFairValue	1600000000000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	22200000000000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	20600000000000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0443	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0414	pure
CY2024Q1	us-gaap	Share Price SharePrice	2.75
CY2024Q1	us-gaap	Share Price SharePrice	4.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings	21169150	usd
CY2024Q1	sti	Fair Value Of Warrants Gain Loss FairValueOfWarrantsGainLoss	8431850	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2024Q1	us-gaap	Gross Profit GrossProfit		usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69800000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78198418	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2023Q1	sti	Cash Received From Nubi Trust CashReceivedFromNUBITrust		usd
CY2023Q1	sti	Discount Payment Related To Non Redemption Agreement DiscountPaymentRelatedToNonRedemptionAgreement		usd
CY2023Q1	sti	Payment For Reimbursement Of Consideration Shares Related To The Forward Purchase Agreement PaymentForReimbursementOfConsiderationSharesRelatedToTheForwardPurchaseAgreement		usd
CY2023Q1	sti	Payment For Reimbursement Of Recycled Shares Related To Forward Purchase Agreement PaymentForReimbursementOfRecycledSharesRelatedToForwardPurchaseAgreement		usd
CY2023Q1	sti	Business Combination BusinessCombination		usd
CY2023Q1	sti	Inflow From Merger InflowFromMerger		usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001881551

Files In Submission

Name	View Source	Status
0001213900-24-050479-index-headers.html	Edgar Link	pending
0001213900-24-050479-index.html	Edgar Link	pending
0001213900-24-050479.txt	Edgar Link	pending
0001213900-24-050479-xbrl.zip	Edgar Link	pending
ea0206183-10q_solidion.htm	Edgar Link	pending
ea020618301ex31-1_solidion.htm	Edgar Link	pending
ea020618301ex31-2_solidion.htm	Edgar Link	pending
ea020618301ex32-1_solidion.htm	Edgar Link	pending
ea020618301ex32-2_solidion.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0206183-10q_solidion_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sti-20240331.xsd	Edgar Link	pending
sti-20240331_cal.xml	Edgar Link	unprocessable
sti-20240331_def.xml	Edgar Link	unprocessable
sti-20240331_lab.xml	Edgar Link	unprocessable
sti-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STI
Solidion Technology Inc. Stock $sti

2024 Q1 Form 10-Q Financial Statement

#000121390024050479 Filed on June 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI Solidion Technology Inc. Stock $sti

2024 Q1 Form 10-Q Financial Statement

#000121390024050479 Filed on June 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STI
Solidion Technology Inc. Stock $sti